US Patent 10646551 Rapid-acting insulin formulation comprising a substituted anionic compound
Patent 10646551 was granted and assigned to Adocia on May, 2020 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 10646551 Rapid-acting insulin formulation comprising a substituted anionic compound
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.